Cohesin-dependent regulation of gene expression during differentiation is lost in cohesin-mutated myeloid malignancies.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
12 12 2019
Historique:
received: 10 05 2019
accepted: 04 09 2019
pubmed: 14 9 2019
medline: 31 3 2020
entrez: 14 9 2019
Statut: ppublish

Résumé

Cohesin complex disruption alters gene expression, and cohesin mutations are common in myeloid neoplasia, suggesting a critical role in hematopoiesis. Here, we explore cohesin dynamics and regulation of hematopoietic stem cell homeostasis and differentiation. Cohesin binding increases at active regulatory elements only during erythroid differentiation. Prior binding of the repressive Ets transcription factor Etv6 predicts cohesin binding at these elements and Etv6 interacts with cohesin at chromatin. Depletion of cohesin severely impairs erythroid differentiation, particularly at Etv6-prebound loci, but augments self-renewal programs. Together with corroborative findings in acute myeloid leukemia and myelodysplastic syndrome patient samples, these data suggest cohesin-mediated alleviation of Etv6 repression is required for dynamic expression at critical erythroid genes during differentiation and how this may be perturbed in myeloid malignancies.

Identifiants

pubmed: 31515253
pii: S0006-4971(20)73150-2
doi: 10.1182/blood.2019001553
pmc: PMC7484777
doi:

Substances chimiques

Biomarkers, Tumor 0
Cell Cycle Proteins 0
Chromosomal Proteins, Non-Histone 0
Histones 0
Proto-Oncogene Proteins c-ets 0
Repressor Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2195-2208

Subventions

Organisme : Medical Research Council
ID : MC_PC_12009
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R009708/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C18680/A25508
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2019 by The American Society of Hematology.

Références

Nature. 2009 Jul 16;460(7253):410-3
pubmed: 19458616
Science. 2011 Aug 19;333(6045):1039-43
pubmed: 21852505
Mol Cell. 2004 Dec 22;16(6):1003-15
pubmed: 15610742
Genes Dev. 2004 Oct 1;18(19):2336-41
pubmed: 15371326
Cell. 2018 Jan 25;172(3):465-477.e15
pubmed: 29358048
Nature. 2010 Sep 23;467(7314):430-5
pubmed: 20720539
Mol Cell. 2015 Jun 18;58(6):1028-39
pubmed: 25982114
Mol Cell. 2006 Sep 15;23(6):787-99
pubmed: 16962805
Cell. 1997 Oct 3;91(1):35-45
pubmed: 9335333
Nat Genet. 2013 Dec;45(12):1464-9
pubmed: 24121791
Nature. 2018 Mar 1;555(7694):54-60
pubmed: 29466336
Nucleic Acids Res. 2017 Jan 4;45(D1):D777-D783
pubmed: 27899578
Blood. 2013 Nov 21;122(22):3616-27; quiz 3699
pubmed: 24030381
Genes Dev. 2008 Nov 15;22(22):3089-114
pubmed: 19056890
Cell. 2017 Oct 5;171(2):305-320.e24
pubmed: 28985562
Blood. 2015 Feb 26;125(9):1367-76
pubmed: 25550361
Nat Genet. 2017 Feb;49(2):204-212
pubmed: 27992414
J Exp Med. 2015 Oct 19;212(11):1819-32
pubmed: 26438361
Mol Cell. 2013 Mar 7;49(5):825-37
pubmed: 23473601
EMBO J. 1998 Oct 1;17(19):5744-56
pubmed: 9755174
Cell Stem Cell. 2010 Oct 8;7(4):532-44
pubmed: 20887958
Cell Stem Cell. 2017 Oct 5;21(4):547-555.e8
pubmed: 28985529
J Exp Med. 2015 Oct 19;212(11):1833-50
pubmed: 26438359
Cell. 2014 Oct 9;159(2):374-387
pubmed: 25303531
N Engl J Med. 2013 May 30;368(22):2059-74
pubmed: 23634996
N Engl J Med. 2016 Jun 9;374(23):2209-2221
pubmed: 27276561
Cell Rep. 2016 Mar 29;14(12):2988-3000
pubmed: 26997282
Blood. 2014 Sep 11;124(11):1790-8
pubmed: 25006131
Nature. 2018 Oct;562(7728):526-531
pubmed: 30333627
Nat Immunol. 2018 Sep;19(9):932-941
pubmed: 30127433
Nat Genet. 2013 Oct;45(10):1232-7
pubmed: 23955599
Blood. 2014 Jul 3;124(1):121-33
pubmed: 24855208
Nat Protoc. 2016 Feb;11(2):316-26
pubmed: 26797456
Cell Stem Cell. 2015 Dec 3;17(6):675-688
pubmed: 26607380
PLoS Genet. 2014 Jul 10;10(7):e1004475
pubmed: 25010205
Nat Commun. 2015 Jan 09;6:5901
pubmed: 25574665
Leukemia. 2014 Feb;28(2):241-7
pubmed: 24220272
J Vis Exp. 2018 Jun 28;(136):
pubmed: 30010637
J Biol Chem. 2018 Jan 19;293(3):1054-1069
pubmed: 29175904
Blood. 2016 Aug 25;128(8):e20-31
pubmed: 27365425

Auteurs

Daniel Sasca (D)

Wellcome Trust-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom.
Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
Department of Hematology, Oncology and Pneumology, University Medical Center Mainz, Mainz, Germany.

Haiyang Yun (H)

Wellcome Trust-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom.
Department of Haematology, University of Cambridge, Cambridge, United Kingdom.

George Giotopoulos (G)

Wellcome Trust-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom.
Department of Haematology, University of Cambridge, Cambridge, United Kingdom.

Jakub Szybinski (J)

Department of Hematology, Oncology and Pneumology, University Medical Center Mainz, Mainz, Germany.

Theo Evan (T)

Wellcome Trust-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom.
Department of Haematology, University of Cambridge, Cambridge, United Kingdom.

Nicola K Wilson (NK)

Wellcome Trust-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom.
Department of Haematology, University of Cambridge, Cambridge, United Kingdom.

Moritz Gerstung (M)

European Bioinformatic Institute, Genome Campus, Hinxton, United Kingdom.

Paolo Gallipoli (P)

Wellcome Trust-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom.
Department of Haematology, University of Cambridge, Cambridge, United Kingdom.

Anthony R Green (AR)

Wellcome Trust-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom.
Department of Haematology, University of Cambridge, Cambridge, United Kingdom.

Robert Hills (R)

Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.

Nigel Russell (N)

Department of Haematology, University of Nottingham, Nottingham, United Kingdom.

Cameron S Osborne (CS)

Department of Medical and Molecular Genetics, Kings College London, United Kingdom.

Elli Papaemmanuil (E)

Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY; and.

Berthold Göttgens (B)

Wellcome Trust-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom.
Department of Haematology, University of Cambridge, Cambridge, United Kingdom.

Peter Campbell (P)

Cancer, Ageing and Somatic Mutation Programme, Wellcome Trust Sanger Institute, Genome Campus, Hinxton, United Kingdom.

Brian J P Huntly (BJP)

Wellcome Trust-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom.
Department of Haematology, University of Cambridge, Cambridge, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH